PS-341 and Doxorubicin in Treating Patients With Advanced Solid Tumors - Related Studies

PS-341 and Doxorubicin in Treating Patients With Advanced Solid Tumors

This study has been completed.

Study NCT00023855. Last updated on July 23, 2008. Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Interventions listed in this trial
		bortezomib
		doxorubicin hydrochloride

2	Additional drug interventions recognized in this trial
		Doxorubicin

3	More general drug interventions related to this trial
		Antibiotics, Antineoplastic
		Antineoplastic Agents
		Enzyme Inhibitors
		Molecular Mechanisms of Pharmacological Action
		Pharmacologic Actions
		Protease Inhibitors
		Therapeutic Uses

4	Sponsors listed in this trial
		University of Wisconsin, Madison
		National Cancer Institute (NCI)